BADLANDS RESOURCES INC (BLDS.CA) Fundamental Analysis & Valuation

TSX-V:BLDSCA0566001099

Current stock price

0.15 CAD
0 (0%)
Last:

This BLDS.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BLDS.CA Profitability Analysis

1.1 Basic Checks

  • BLDS had negative earnings in the past year.
  • In the past year BLDS has reported a negative cash flow from operations.
  • BLDS had negative earnings in each of the past 5 years.
  • In the past 5 years BLDS always reported negative operating cash flow.
BLDS.CA Yearly Net Income VS EBIT VS OCF VS FCFBLDS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • BLDS has a worse Return On Assets (-1106.93%) than 88.18% of its industry peers.
Industry RankSector Rank
ROA -1106.93%
ROE N/A
ROIC N/A
ROA(3y)-510.54%
ROA(5y)-309.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLDS.CA Yearly ROA, ROE, ROICBLDS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BLDS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLDS.CA Yearly Profit, Operating, Gross MarginsBLDS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

0

2. BLDS.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BLDS remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, BLDS has more shares outstanding
  • Compared to 1 year ago, BLDS has a worse debt to assets ratio.
BLDS.CA Yearly Shares OutstandingBLDS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BLDS.CA Yearly Total Debt VS Total AssetsBLDS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -77.78, we must say that BLDS is in the distress zone and has some risk of bankruptcy.
  • BLDS has a worse Altman-Z score (-77.78) than 82.52% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -77.78
ROIC/WACCN/A
WACCN/A
BLDS.CA Yearly LT Debt VS Equity VS FCFBLDS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

2.3 Liquidity

  • BLDS has a Current Ratio of 0.10. This is a bad value and indicates that BLDS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.10, BLDS is not doing good in the industry: 82.52% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.10 indicates that BLDS may have some problems paying its short term obligations.
  • The Quick ratio of BLDS (0.10) is worse than 82.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
BLDS.CA Yearly Current Assets VS Current LiabilitesBLDS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

0

3. BLDS.CA Growth Analysis

3.1 Past

  • The earnings per share for BLDS have decreased strongly by -1141.47% in the last year.
EPS 1Y (TTM)-1141.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. BLDS.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • BLDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLDS.CA Price Earnings VS Forward Price EarningsBLDS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLDS.CA Per share dataBLDS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. BLDS.CA Dividend Analysis

5.1 Amount

  • BLDS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BLDS.CA Fundamentals: All Metrics, Ratios and Statistics

BADLANDS RESOURCES INC

TSX-V:BLDS (4/13/2026, 7:00:00 PM)

0.15

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-26
Earnings (Next)07-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.98%
Ins Owner ChangeN/A
Market Cap1.70M
Revenue(TTM)N/A
Net Income(TTM)-11.85M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.27
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1106.93%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-510.54%
ROA(5y)-309.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z -77.78
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1141.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.51%
OCF growth 3YN/A
OCF growth 5YN/A

BADLANDS RESOURCES INC / BLDS.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BADLANDS RESOURCES INC?

ChartMill assigns a fundamental rating of 0 / 10 to BLDS.CA.


What is the valuation status for BLDS stock?

ChartMill assigns a valuation rating of 0 / 10 to BADLANDS RESOURCES INC (BLDS.CA). This can be considered as Overvalued.


How profitable is BADLANDS RESOURCES INC (BLDS.CA) stock?

BADLANDS RESOURCES INC (BLDS.CA) has a profitability rating of 0 / 10.